NGVT - Ingevity Corporation
NYSE
->
Basic Materials
->
Specialty Chemicals
North Charleston,
United States
Type: Equity
NGVT price evolution
NGVT
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $107.4 | $88.5 | $95.9 | |
| Short term investments | ||||
| Net receivables | $189.9 | $213.4 | $191.3 | $182 |
| Inventory | $261 | $302 | $325.5 | $308.8 |
| Total current assets | $636.8 | $685.8 | $669.2 | $658.6 |
| Long term investments | $174.4 | $173.9 | $178.3 | |
| Property, plant & equipment | $727.3 | $782.5 | $790.1 | $829.3 |
| Goodwill & intangible assets | $472.7 | $828.7 | $863.6 | |
| Total noncurrent assets | $1590.4 | $1897.7 | $1964.7 | |
| Total investments | $174.4 | $173.9 | $178.3 | |
| Total assets | $2211.6 | $2276.2 | $2566.9 | $2623.3 |
| Current liabilities | ||||
| Accounts payable | $96.5 | $142.4 | $153.1 | $158.4 |
| Deferred revenue | ||||
| Short long term debt | $121.5 | $103.5 | $103.1 | |
| Total current liabilities | $360.8 | $357.8 | $351.7 | $362.9 |
| Long term debt | $1397.6 | $1442.9 | $1453.7 | $1431.4 |
| Total noncurrent liabilities | $1633.6 | $1647 | $1629 | |
| Total debt | $1564.4 | $1557.2 | $1534.5 | |
| Total liabilities | $1997.1 | $1991.4 | $1998.7 | $1991.9 |
| Shareholders' equity | ||||
| Retained earnings | $555.4 | $662.6 | $946.3 | $1002.3 |
| Other shareholder equity | -$3.5 | -$37.5 | -$35.6 | -$26.7 |
| Total shareholder equity | $284.8 | $568.2 | $631.4 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $95.9 | $76.7 | $275.4 | $257.7 |
| Short term investments | ||||
| Net receivables | $182 | $249.3 | $161.7 | $148 |
| Inventory | $308.8 | $335 | $241.2 | $189 |
| Total current assets | $658.6 | $679 | $724.9 | $628.7 |
| Long term investments | $178.3 | $187.8 | $76.1 | $73.6 |
| Property, plant & equipment | $829.3 | $855.3 | $772.1 | $752.7 |
| Goodwill & intangible assets | $863.6 | $923.3 | $779.6 | $818.6 |
| Total noncurrent assets | $1964.7 | $2057.5 | $1744.1 | $1705.8 |
| Total investments | $178.3 | $187.8 | $76.1 | $73.6 |
| Total assets | $2623.3 | $2736.5 | $2469 | $2334.5 |
| Current liabilities | ||||
| Accounts payable | $158.4 | $174.8 | $125.8 | $104.2 |
| Deferred revenue | ||||
| Short long term debt | $103.1 | $17.4 | $37 | $42.2 |
| Total current liabilities | $362.9 | $303.5 | $268.9 | $223.4 |
| Long term debt | $1431.4 | $1472.5 | $1286.2 | $1302.1 |
| Total noncurrent liabilities | $1629 | $1734.7 | $1526.3 | $1469 |
| Total debt | $1534.5 | $1530.7 | $1323.2 | $1344.3 |
| Total liabilities | $1991.9 | $2038.2 | $1795.2 | $1692.4 |
| Shareholders' equity | ||||
| Retained earnings | $1002.3 | $1007.7 | $796.1 | $678 |
| Other shareholder equity | -$26.7 | -$46.8 | $13.1 | $4.7 |
| Total shareholder equity | $631.4 | $698.3 | $673.8 | $642.1 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $390.6 | $340.1 | $371.7 | |
| Cost of revenue | $267.4 | $240.4 | $312.2 | |
| Gross Profit | $123.2 | $99.7 | $59.5 | |
| Operating activities | ||||
| Research & development | $7.3 | $6.8 | $7.2 | |
| Selling, general & administrative | $41.4 | $47.2 | $43.4 | |
| Total operating expenses | $410.7 | $117.1 | $171.2 | |
| Operating income | -$287.5 | -$17.4 | -$111.7 | |
| Income from continuing operations | ||||
| EBIT | -$311.4 | -$49.6 | -$125 | |
| Income tax expense | -$50.9 | -$15.9 | -$37.2 | |
| Interest expense | $23.2 | $22.3 | $29 | |
| Net income | ||||
| Net income | -$283.7 | -$56 | -$116.8 | |
| Income (for common shares) | -$283.7 | -$56 | -$116.8 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1692.1 | $1668.3 | $1391.5 | $1216.1 |
| Cost of revenue | $1220.2 | $1098.2 | $878.7 | $750.6 |
| Gross Profit | $471.9 | $570.1 | $512.8 | $465.5 |
| Operating activities | ||||
| Research & development | $31.8 | $30.3 | $26.3 | $22.6 |
| Selling, general & administrative | $183.7 | $198.8 | $179.3 | $149.4 |
| Total operating expenses | $389.3 | $247.9 | $222.4 | $192.3 |
| Operating income | $82.6 | $322.2 | $290.4 | $273.2 |
| Income from continuing operations | ||||
| EBIT | $83.2 | $331.4 | $214.5 | $282.2 |
| Income tax expense | -$4.7 | $58 | $44.7 | $53.7 |
| Interest expense | $93.3 | $61.8 | $51.7 | $47.1 |
| Net income | ||||
| Net income | -$5.4 | $211.6 | $118.1 | $181.4 |
| Income (for common shares) | -$5.4 | $211.6 | $118.1 | $181.4 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$283.7 | -$56 | -$116.8 | |
| Operating activities | ||||
| Depreciation | $32.1 | $34.5 | $29.9 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.4 | $4.3 | $2.3 | |
| Total cash flows from operations | $29.7 | -$12.1 | $44.6 | |
| Investing activities | ||||
| Capital expenditures | -$18.1 | -$16.6 | -$29.2 | |
| Investments | ||||
| Total cash flows from investing | -$51.5 | -$17.8 | -$16.3 | -$21 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | $10.5 | $26 | -$6.5 | |
| Total cash flows from financing | $27.4 | $10.3 | $23.4 | -$6.5 |
| Effect of exchange rate | $1.6 | -$2 | -$1.8 | $2.7 |
| Change in cash and equivalents | $41.6 | $22.2 | -$5 | $17.1 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$5.4 | $211.6 | $118.1 | $181.4 |
| Operating activities | ||||
| Depreciation | $141.4 | $124.9 | $127.2 | $118.2 |
| Business acquisitions & disposals | -$344.5 | |||
| Stock-based compensation | $10.6 | $16.1 | $12.3 | $8.4 |
| Total cash flows from operations | $205.1 | $313.1 | $293 | $352.4 |
| Investing activities | ||||
| Capital expenditures | -$109.8 | -$142.5 | -$103.8 | -$105.9 |
| Investments | $29.1 | -$62.7 | -$35.3 | -$2 |
| Total cash flows from investing | -$77.3 | -$553.9 | -$140.6 | -$110.6 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$87.4 | -$141.1 | -$104.7 | -$84.4 |
| Net borrowings | -$7.7 | $196 | -$26 | $37.4 |
| Total cash flows from financing | -$99.9 | $48.1 | -$133.1 | -$50.2 |
| Effect of exchange rate | -$0.3 | -$6 | -$1.7 | $2.2 |
| Change in cash and equivalents | $27.9 | -$192.7 | $19.3 | $191.6 |
News
Fundamentals
| Market cap | $1.76B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 36.35M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 3.15 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.76 |
| Quick ratio | 1.04 |